Trulicity vs Ozempic: Weight Loss & Differences

Trulicity vs Ozempic comes down to two once-weekly GLP-1 injections approved for type 2 diabetes: Trulicity is dulaglutide and Ozempic is semaglutide. Both lower blood sugar and can reduce weight, but in head-to-head data Ozempic produces roughly double the weight loss of Trulicity. Neither is FDA-approved for weight loss on its own.

If you have been prescribed one of these medicines, or you are weighing your options with a clinician, it helps to understand how they are alike and where they differ. Both belong to the same drug family and share the same core mechanism, so the differences are more about degree than kind. This article walks through the practical distinctions in dosing, effectiveness, side effects, and convenience so you can have a better-informed conversation with your prescriber.

It is worth setting expectations up front. Because these are diabetes medicines rather than dedicated weight drugs, the goal your clinician is treating is usually blood sugar control, with weight change as a welcome secondary benefit. That framing shapes everything below: the doses are chosen for glucose targets, the trial evidence measured A1c first, and the weight numbers are averages that hide a lot of individual variation. Some people respond strongly to one drug and modestly to the other, so your own experience may differ from the group averages reported in studies.

Trulicity vs Ozempic at a glance

Trulicity (dulaglutide) is made by Eli Lilly. Ozempic (semaglutide) is made by Novo Nordisk. Both are GLP-1 receptor agonists, meaning they mimic a natural gut hormone called glucagon-like peptide-1 that signals fullness, slows stomach emptying, and prompts the pancreas to release insulin when blood sugar is high. If you want a deeper look at that mechanism, see how semaglutide works for weight loss.

Feature	Trulicity	Ozempic
Active ingredient	Dulaglutide	Semaglutide
Drug class	GLP-1 receptor agonist	GLP-1 receptor agonist
Dosing frequency	Once weekly (subcutaneous)	Once weekly (subcutaneous)
Doses	0.75 mg, 1.5 mg, 3 mg, 4.5 mg	0.25 mg, 0.5 mg, 1 mg, 2 mg
FDA-approved use	Type 2 diabetes	Type 2 diabetes
Weight loss (typical)	About 5 to 7 lb	About 10 to 14 lb
A1c reduction	Lower than Ozempic in trials	Greater in trials

Dosing and how you take them

Both drugs are self-injected under the skin once a week, so weekly dosing is not a point of difference. Where they diverge is the ladder of available strengths and how the injector feels in your hand.

Trulicity comes in 0.75 mg, 1.5 mg, 3 mg, and 4.5 mg strengths. Ozempic comes in 0.25 mg, 0.5 mg, 1 mg, and 2 mg strengths, and the 0.25 mg dose is a starter step used to ease your body into treatment rather than a therapeutic target. With both medicines, clinicians typically begin low and step the dose up over several weeks to reduce nausea and other early effects. Your dose is set by your prescriber based on your response and tolerance; this article does not recommend any specific dose or dose change.

Convenience is a real-world tiebreaker for some people. Trulicity uses an auto-injector with the needle hidden, and you press it against the skin without ever attaching a needle or seeing it. People who are needle-averse often find this simpler, and the single-use design means there is little to assemble. Ozempic uses a dial pen where you attach a small needle and select the dose, which gives flexibility but adds a step. Neither approach is clearly superior; the better choice is the one you will actually use consistently every week, since missed doses undercut both blood sugar control and any weight benefit.

Storage and handling are broadly similar for both pens. Unopened, they are kept refrigerated, and once in use they can generally be held at room temperature for a limited window per the labeling. Your pharmacist can walk you through the specifics for the exact pen you receive, and the patient instructions that come in the box are the authoritative source for injection technique and rotation of injection sites.

Trulicity vs Ozempic for weight loss

This is the question most people arrive with. The clearest evidence comes from the SUSTAIN-7 trial, a direct head-to-head comparison in which semaglutide (Ozempic) lowered both A1c and body weight more than dulaglutide (Trulicity). In practical terms, Ozempic produces roughly double the weight loss of Trulicity: on average about 10 to 14 lb for Ozempic compared with about 5 to 7 lb for Trulicity at the compared doses.

It is worth being clear about labeling. Neither Trulicity nor Ozempic is FDA-approved for weight loss. Any weight change is a secondary effect of a diabetes medicine, and results vary widely from person to person. If your priority is weight, the on-label options in this drug family are Wegovy (semaglutide) and Zepbound (tirzepatide), both approved specifically for chronic weight management. Trulicity has no higher-dose, weight-approved version. You can compare typical outcomes across the class in our roundup of GLP-1 weight loss results by drug and see how the leading options stack up in the best GLP-1 for weight loss.

Because Ozempic and Trulicity are diabetes drugs, it also helps to know which products carry weight-management approval. Our overview of FDA-approved GLP-1 medications lays out which drug is cleared for which purpose so you are not comparing apples to oranges.

Side effects: mostly the same family

Both medicines share the side effect profile of the GLP-1 class, so most differences are a matter of intensity rather than type. The most common effects are gastrointestinal: nausea, diarrhea, vomiting, and constipation. These tend to cluster in the first weeks and around each dose increase, then ease as your body adapts. For a week-by-week sense of what to expect, see our GLP-1 side effects timeline.

At lower doses, Trulicity may cause fewer GI side effects than Ozempic for some people. At higher doses that gap tends to narrow, so the trade is not fixed. Both carry a boxed warning about thyroid C-cell tumors based on rodent studies, and both should be avoided by people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2. Low blood sugar (hypoglycemia) is uncommon with either drug on its own but becomes a meaningful risk when combined with insulin or a sulfonylurea, in which case the other medicine may need adjusting by your clinician. For a fuller picture specific to semaglutide, our page on Ozempic side effects goes into more detail.

Which one is better for you?

There is no single winner for everyone. If your main goal is stronger blood sugar control and more weight reduction, the evidence points to Ozempic (semaglutide) as the more potent of the two. If your priorities are a very simple, needle-hidden injection and possibly gentler early side effects at a lower dose, Trulicity may fit better. Cost and coverage also matter: both are widely covered for type 2 diabetes, but your out-of-pocket price depends on your specific insurance plan and formulary.

It is also worth remembering that this is not a two-horse race. Tirzepatide (sold as Mounjaro for diabetes and Zepbound for weight) targets two hormone receptors and often outperforms both drugs here. If you want to see how semaglutide compares against that newer option, read our breakdown of Ozempic vs Mounjaro.